ijms-logo

Journal Browser

Journal Browser

Oxidative Stress and Inflammation in Parkinson’s Disease and Mood Disorders

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".

Deadline for manuscript submissions: closed (20 March 2024) | Viewed by 4208

Special Issue Editors


E-Mail Website
Guest Editor
Department of Neurobiology, Maj Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, 31-343 Kraków, Poland
Interests: cognition; depression; anxiety; DSCAM; GABA; COX-2; mGluRs
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Human Physiology, Institute of Medical Sciences, Medical College of Rzeszów University, Kopisto 2a, 35-310 Rzeszow, Poland
Interests: depression; mental disorders; glutamate transmission; glutamate receptors; epigenetics; animal models of depression

Special Issue Information

Dear Colleagues,

The involvement of inflammation and oxidative stress in the pathogenesis of neurological and psychiatric diseases, including Parkinson's disease and mood disorders, has been demonstrated. Mediators of the immune response (e.g., TNF-α, IL-1 and IL-6) can directly cause neuronal toxicity. They can cross the blood–brain barrier, but are also produced by immunocompetent cells (e.g., glial and microglia cells) in the CNS. Pro-inflammatory factors are important communication components between the immune, neurotransmitter and (neuro)endocrine systems. Cytokines are critical modulators of neurotransmitter turnover, including key monoamines (serotonin, norepinephrine, glutamate or dopamine) in mood regulation. In addition, they can induce oxidative processes. Disruption of the pro-oxidant–antioxidant balance in a cell leads to the disruption of its structure and function and ultimately to cell death.

The comorbidity of depression with Parkinson's disease has been documented. PD symptoms are caused by an approximate 50% loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc), leading to a reduction in dopamine levels of about 80% in the striatum. However, the onset of the disease is unknown. Paying more attention to inflammatory and oxidative processes may be vital to understanding the pathophysiology of these diseases. We invite all researchers working on this important topic to present their research and thoughts.

Dr. Katarzyna Stachowicz
Dr. Magdalena Sowa-Kućma
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • oxidative stress
  • inflammation
  • Parkinson’s disease
  • mood disorders
  • depression
  • mechanisms of depression
  • cytokines
  • animal models
  • human study

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

16 pages, 1340 KiB  
Article
Evaluation of Antidepressive-like Behaviours and Oxidative Stress Parameters in Mice Receiving Imipramine-Zinc Complex Compound
by Aleksandra Szopa, Mariola Herbet, Ewa Poleszak, Anna Serefko, Agnieszka Czylkowska, Iwona Piątkowska-Chmiel, Kamila Kasperek, Andrzej Wróbel, Paulina Prewencka and Bernadeta Szewczyk
Int. J. Mol. Sci. 2023, 24(18), 14157; https://doi.org/10.3390/ijms241814157 - 15 Sep 2023
Viewed by 735
Abstract
The study aimed to evaluate the antidepressant-like effects of an imipramine-zinc (IMI-Zn) complex compound on mice and assess the level of oxidative stress parameters. The research also investigated whether the IMI-Zn complex showed superior antidepressant activity compared to individual treatments of both compounds [...] Read more.
The study aimed to evaluate the antidepressant-like effects of an imipramine-zinc (IMI-Zn) complex compound on mice and assess the level of oxidative stress parameters. The research also investigated whether the IMI-Zn complex showed superior antidepressant activity compared to individual treatments of both compounds at effective doses and their joint administration at subtherapeutic doses. The study was conducted on mice. Forced swim (FST), tail suspension (TST), and locomotor activity tests were used for behavioral studies. The results demonstrated the IMI-Zn complex’s dose-dependent antidepressant potential when orally administered to mice. Its efficacy was similar to the separate administration of therapeutic doses of imipramine (IMI) and zinc (Zn) and their joint administration at subtherapeutic doses. Moreover, subjecting mice to acute stress did not significantly affect the activity of on glutathione peroxidase (GPX), glutathione reductase (GR), and total antioxidant status (TAS), possibly due to the short exposure time to the stress stimulus. By developing the IMI-Zn complex, it might be possible to simplify the treatment approach, potentially improving patient compliance by combining the therapeutic effects of both IMI and Zn within a single compound, thus addressing one of the contributing factors to non-compliance in depression therapy. The IMI-Zn complex could be a valuable strategy to optimize therapeutic outcomes and balance efficacy and tolerability. Full article
Show Figures

Figure 1

Review

Jump to: Research

14 pages, 1639 KiB  
Review
Physicochemical Principles of Adhesion Mechanisms in the Brain
by Katarzyna Stachowicz
Int. J. Mol. Sci. 2023, 24(6), 5070; https://doi.org/10.3390/ijms24065070 - 7 Mar 2023
Cited by 4 | Viewed by 2908
Abstract
The brain functions through neuronal circuits and networks that are synaptically connected. This type of connection can exist due to physical forces that interact to stabilize local contacts in the brain. Adhesion is a fundamental physical phenomenon that allows different layers, phases, and [...] Read more.
The brain functions through neuronal circuits and networks that are synaptically connected. This type of connection can exist due to physical forces that interact to stabilize local contacts in the brain. Adhesion is a fundamental physical phenomenon that allows different layers, phases, and tissues to connect. Similarly, synaptic connections are stabilized by specialized adhesion proteins. This review discusses the basic physical and chemical properties of adhesion. Cell adhesion molecules (CAMs) such as cadherins, integrins, selectins, and immunoglobulin family of cell adhesion molecules (IgSF) will be discussed, and their role in physiological and pathological brain function. Finally, the role of CAMs at the synapse will be described. In addition, methods for studying adhesion in the brain will be presented. Full article
Show Figures

Figure 1

Back to TopTop